These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28587476)

  • 1. Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
    Freckmann G; Baumstark A; Pleus S
    J Diabetes Sci Technol; 2017 Nov; 11(6):1240-1246. PubMed ID: 28587476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why the New FDA Glucose Meter POCT Guidance Is Disappointing.
    Krouwer JS
    J Diabetes Sci Technol; 2017 Nov; 11(6):1274. PubMed ID: 27923882
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting the New FDA Standard for Accuracy of Self-Monitoring Blood Glucose Test Systems Intended for Home Use by Lay Users.
    Katz LB; Stewart L; King D; Cameron H
    J Diabetes Sci Technol; 2020 Sep; 14(5):912-916. PubMed ID: 32059615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy: Relevant Differences Among ISO 15197:2003, ISO 15197:2013, and Current FDA Recommendations.
    Freckmann G; Schmid C; Baumstark A; Rutschmann M; Haug C; Heinemann L
    J Diabetes Sci Technol; 2015 Jul; 9(4):885-94. PubMed ID: 25872965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Precision and Bias Specifications Required to Achieve the 2018 FDA Guidance Criteria for Glucose Meter Performance Using Simulation Models.
    Lyon AW; Lyon ME
    J Diabetes Sci Technol; 2020 May; 14(3):513-518. PubMed ID: 31752535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difference Analysis of System Accuracy Criteria between Self-Monitoring Blood Glucose Test System and Point-of-Care Blood Glucose Monitoring Systems].
    Song W; Wang J; Xu Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Apr; 44(4):338-342. PubMed ID: 32762210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of Blood Glucose Monitor Accuracy.
    King F; Ahn D; Hsiao V; Porco T; Klonoff DC
    Diabetes Technol Ther; 2018 Dec; 20(12):843-856. PubMed ID: 30376362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why the Diabetes Technology Society Surveillance Protocol for Glucose Meters Needs to Be Revised.
    Krouwer JS
    J Diabetes Sci Technol; 2017 Nov; 11(6):1247-1249. PubMed ID: 28376646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy evaluation of four blood glucose monitoring systems according to ISO 15197:2003 and ISO 15197:2013 criteria.
    Chen H; Yao Q; Dong Y; Tang Z; Li R; Cai B; Wang R; Chen Q
    Prim Care Diabetes; 2019 Jun; 13(3):252-258. PubMed ID: 30770203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarm characterization for a continuous glucose monitor that replaces traditional blood glucose monitoring.
    McGarraugh G
    J Diabetes Sci Technol; 2010 Jan; 4(1):49-56. PubMed ID: 20167167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FDA panel advises approval of the first continuous glucose sensor.
    Ginsberg BH
    Diabetes Technol Ther; 1999; 1(2):203-4. PubMed ID: 11475294
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves new Glucose Monitoring System.
    Klonoff DC
    Diabetes Technol Ther; 1999; 1(3):349. PubMed ID: 11475279
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197.
    Jendrike N; Baumstark A; Pleus S; Mende J; Haug C; Freckmann G
    J Diabetes Sci Technol; 2019 Mar; 13(2):235-241. PubMed ID: 30547683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy Evaluation of 19 Blood Glucose Monitoring Systems Manufactured in the Asia-Pacific Region: A Multicenter Study.
    Yu-Fei W; Wei-Ping J; Ming-Hsun W; Miao-O C; Ming-Chang H; Chi-Pin W; Ming-Shih L
    J Diabetes Sci Technol; 2017 Sep; 11(5):953-965. PubMed ID: 28480733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: A Potentially Risky Decision.
    Shapiro AR
    JAMA; 2017 Oct; 318(16):1541-1542. PubMed ID: 28910454
    [No Abstract]   [Full Text] [Related]  

  • 16. Tighter accuracy standards within point-of-care blood glucose monitoring: how six commonly used systems compare.
    Robinson CS; Sharp P
    J Diabetes Sci Technol; 2012 May; 6(3):547-54. PubMed ID: 22768885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance Evaluation of Three Blood Glucose Monitoring Systems Using ISO 15197: 2013 Accuracy Criteria, Consensus and Surveillance Error Grid Analyses, and Insulin Dosing Error Modeling in a Hospital Setting.
    Bedini JL; Wallace JF; Pardo S; Petruschke T
    J Diabetes Sci Technol; 2015 Oct; 10(1):85-92. PubMed ID: 26445813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose.
    Jendrike N; Rittmeyer D; Pleus S; Baumstark A; Haug C; Freckmann G
    J Diabetes Sci Technol; 2015 Jul; 9(4):934-5. PubMed ID: 25901021
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of Cleared Blood Glucose Monitors.
    Klonoff DC; Prahalad P
    J Diabetes Sci Technol; 2015 Jul; 9(4):895-910. PubMed ID: 25990294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood glucose meters.
    Wahowiak L
    Diabetes Forecast; 2014 Jan; 67(1):42-52. PubMed ID: 25868294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.